Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

Kun Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2522-2182; OpenAlex author ID A5100366649. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 3

  1. The ufmylation modification of ribosomal protein L10 in the development of pancreatic adenocarcinoma. Co-author DOI 10.1038/s41419-023-05877-y↗
  2. The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting… Co-author DOI 10.1016/j.molonc.2012.10.011↗
  3. miR-301a promotes pancreatic cancer cell proliferation by directly inhibiting Bim expression. Last author DOI 10.1002/jcb.24200↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yijun Chen · 1 shared paper, 2023 · strength 0.20
  2. Zhen Chen · 2 shared papers, 2012–2013 · strength 0.07
  3. Peng Wang · 2 shared papers, 2012–2013 · strength 0.07
  4. Song Gao · 1 shared paper, 2012 · strength 0.04
  5. Luming Liu · 1 shared paper, 2013 · strength 0.03
  6. Juan Zhang · 1 shared paper, 2013 · strength 0.03
  7. Liping Zhuang · 1 shared paper, 2013 · strength 0.03
  8. Zhiqiang Meng · 1 shared paper, 2013 · strength 0.03
  9. Jie Fan · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.